ArticleInternational neurourology journal2011
Regenerative medicine strategies for treating neurogenic bladder.
Article in International neurourology journal, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 48 citations in OpenAlex.
- MMP-2 Responsive Functional Bladder Acellular Matrix Scaffold Combined With Urine Derived Stem Cells for Bladder Nerve Regeneration.Chembiochem : a European journal of chemical biology · 2026Article
- Perfusion preparation of the rat bladder decellularized scaffold.Regenerative therapy · 2023Article
- Article
- Tissue Engineering and Regenerative Medicine in Pediatric Urology: Urethral and Urinary Bladder Reconstruction.International journal of molecular sciences · 2022Review
- Urodynamic Parameters in Spinal Cord Injury-Induced Neurogenic Bladder Rats after Stem Cell Transplantation: A Narrative Review.Iranian journal of medical sciences · 2020Review
- Bladder augmentation in children: current problems and experimental strategies for reconstruction.Wiener medizinische Wochenschrift (1946) · 2019Review
- Minimally Invasive and Regenerative Therapeutics.Advanced materials (Deerfield Beach, Fla.) · 2019Review
- The effect of a cyclic uniaxial strain on urinary bladder cells.World journal of urology · 2017Article
- Biocompatibility of different nanostructured TiOProtoplasma · 2016Article
- Production of urothelium from pluripotent stem cells for regenerative applications.Current urology reports · 2015Review
- Applications and implications of heparin and protamine in tissue engineering and regenerative medicine.BioMed research international · 2014Review
- Alternatives to conventional enterocystoplasty in children: a critical review of urodynamic outcomes.Frontiers in pediatrics · 2013Review
- Tissue engineering of urinary bladder and urethra: advances from bench to patients.TheScientificWorldJournal · 2013Review
- Proceedings of the Annual Symposium & Plenary Session on Regenerative Medicine (PASRM).Journal of stem cells & regenerative medicine · 2013Article
- The use of regenerative medicine in the management of invasive bladder cancer.Advances in urology · 2012Article
- The evolution of urogenital tissue engineering.International neurourology journal · 2011Article
- Whyever bladder tissue engineering clinical applications still remain unusual even though many intriguing technological advances have been reached?Il Giornale di chirurgiaReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurogenic bladder is a general term encompassing various neurologic dysfunctions of the bladder and the external urethral sphincter. These can be caused by damage or disease. Therapeutic management options can be conservative, minimally invasive, or surgical. The current standard for surgical management is bladder augmentation using intestinal segments. However, because intestinal tissue possesses different functional characteristics than bladder tissue, numerous complications can ensue, including excess mucus production, urinary stone formation, and malignancy. As a result, investigators have sought after alternative solutions. Tissue engineering is a scientific field that uses combinations of cells and biomaterials to encourage regeneration of new, healthy tissue and offers an alternative approach for the replacement of lost or deficient organs, including the bladder. Promising results using tissue-engineered bladder have already been obtained in children with neurogenic bladder caused by myelomeningocele. Human clinical trials, governed by the Food and Drug Administration, are ongoing in the United States in both children and adults to further evaluate the safety and efficacy of this technology. This review will introduce the principles of tissue engineering and discuss how it can be used to treat refractory cases of neurogenic bladder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.